EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

A 56-Year-Old Male Patient With 21-Hydroxylase Deficiency Presenting With Fatigue: A Case Report

Shunmei Huang, Weizhen Wu, Yue Wu, Jiaqiu Wang, Lijun Zhu, Yunmei Yang, Qin Zhang

British Journal of Hospital Medicine · 17.04.2026 · 87 (4)

DOI: 10.31083/bjhm53026 ↗

Kurz gefasst

Fallbericht in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 17.04.2026. Verfasst von Shunmei Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital, Zhejiang University School of Medicine, 310003 Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Fatigue. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/Background: Congenital adrenal hyperplasia (CAH) results from 21-hydroxylase deficiency (21-OHD), which is the most frequent form of CAH and often presents with atypical symptoms. Patients with non-classic 21-OHD (NC-21-OHD) are particularly susceptible to diagnostic challenges, including misdiagnosis and underdiagnosis. This study reports a case of NC-21-OHD and underscores the associated challenges in its diagnosis, treatment, and clinical management. Case Presentation: This study reports a 56-year-old male patient who presented with fatigue lasting over a year. Initial ultrasound revealed a hypoechoic mass above the left kidney, and further evaluation, including renal tumor evaluation and computed tomography angiography, indicated thickening of the adrenal glands and multiple lesions. Endocrinological assessment revealed reduced luteinizing and follicle-stimulating hormone levels, along with elevated dehydroepiandrosterone sulfate and abnormal corticotropin, ultimately diagnosing the patient with primary adrenal insufficiency. Furthermore, genetic screening identified heterozygous mutations in the CYP21A2 (cytochrome P450, family 21, sub-family A, polypeptide 2) gene, confirming CAH due to NC-21-OHD. The patient was treated with hydrocortisone at a dosage of 20 mg twice a day.

Results

Hydrocortisone therapy resulted in a significant alleviation of fatigue symptoms and a substantial reduction in 17α-hydroxyprogesterone (17-OHP) levels, thereby enhancing the patient’s confidence in disease management.

Conclusion

This case emphasizes the significance of early recognition of nonspecific symptoms, prompt diagnosis, and timely treatment in managing CAH to enhance the overall quality of life and reproductive health in affected individuals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenal Hyperplasia, CongenitalFatigueHumansMaleMiddle AgedSteroid 21-Hydroxylase

Stichwörter der Autor:innen

17α-hydroxyprogesterone21-hydroxylase deficiencycase reportcongenital adrenal hyperplasiafatigue

Substanzen

Steroid 21-Hydroxylase

Autor:innen und Institutionen

  • Department of Geriatrics, The First Affiliated Hospital, Zhejiang University School of Medicine, 310003 Hangzhou, Zhejiang, China.

Zitieren

APA

Huang, S., Wu, W., Wu, Y., Wang, J., Zhu, L., Yang, Y., & Zhang, Q. (2026). A 56-Year-Old Male Patient With 21-Hydroxylase Deficiency Presenting With Fatigue: A Case Report. British Journal of Hospital Medicine, 87(4). https://doi.org/10.31083/bjhm53026

Vancouver

Huang S, Wu W, Wu Y, Wang J, Zhu L, Yang Y, et al. A 56-Year-Old Male Patient With 21-Hydroxylase Deficiency Presenting With Fatigue: A Case Report. British Journal of Hospital Medicine. 2026;87(4). doi:10.31083/bjhm53026

BibTeX
@article{Huang2026,
  author = {Huang, Shunmei and Wu, Weizhen and Wu, Yue and Wang, Jiaqiu and Zhu, Lijun and Yang, Yunmei and Zhang, Qin},
  title = {A 56-Year-Old Male Patient With 21-Hydroxylase Deficiency Presenting With Fatigue: A Case Report},
  journal = {British Journal of Hospital Medicine},
  year = {2026},
  volume = {87},
  number = {4},
  doi = {10.31083/bjhm53026}
}
Kostenlos starten →